| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 6.309 | 666.289 | 927.020 | 1.195.207 | 1.042.352 | 1.159.495 |
| Total Income - EUR | - | - | - | - | 6.309 | 677.878 | 927.087 | 1.201.467 | 1.070.190 | 1.161.410 |
| Total Expenses - EUR | - | - | - | - | 4.737 | 446.476 | 555.445 | 740.653 | 801.204 | 947.477 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.572 | 231.402 | 371.642 | 460.815 | 268.986 | 213.933 |
| Net Profit/Loss - EUR | - | - | - | - | 1.506 | 226.072 | 361.985 | 447.556 | 233.924 | 179.927 |
| Employees | - | - | - | - | 0 | 8 | 11 | 16 | 15 | 11 |
Check the financial reports for the company - Dentax Remedium Company Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 33.969 | 77.983 | 115.789 | 212.554 | 282.307 | 248.555 |
| Current Assets | - | - | - | - | 32.579 | 234.118 | 320.945 | 450.596 | 291.971 | 239.583 |
| Inventories | - | - | - | - | 26.296 | 17.605 | 11.542 | 9.433 | 19.009 | 27.862 |
| Receivables | - | - | - | - | 10 | 8.444 | 3.494 | 35.418 | 25.574 | 39.848 |
| Cash | - | - | - | - | 6.273 | 208.070 | 305.909 | 405.746 | 247.389 | 171.873 |
| Shareholders Funds | - | - | - | - | 1.548 | 227.591 | 340.246 | 564.531 | 433.146 | 278.365 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 64.999 | 84.510 | 96.488 | 98.619 | 141.132 | 209.773 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Dentax Remedium Company Srl